These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 11080041)
1. Telomerase: an unusual target for cytotoxic agents. Corey DR Chem Res Toxicol; 2000 Oct; 13(10):957-60. PubMed ID: 11080041 [No Abstract] [Full Text] [Related]
2. How to inhibit telomerase activity for cancer therapy. Kyo S; Inoue M Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728 [TBL] [Abstract][Full Text] [Related]
3. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs]. Raymond E; Faivre S; Dieras V; Von Hoff D Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365 [TBL] [Abstract][Full Text] [Related]
4. Targeting human telomerase in cancer therapy. Huard S; Autexier C Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725 [TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition as cancer therapy. Saretzki G Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979 [TBL] [Abstract][Full Text] [Related]
9. Telomerase: a target for cancer therapeutics. Shay JW; Wright WE Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889 [TBL] [Abstract][Full Text] [Related]
10. Of telomeres and tumors. Axelrod N Nat Med; 1996 Feb; 2(2):158-9. PubMed ID: 8574955 [TBL] [Abstract][Full Text] [Related]
11. Natural and pharmacological regulation of telomerase. Mergny JL; Riou JF; Mailliet P; Teulade-Fichou MP; Gilson E Nucleic Acids Res; 2002 Feb; 30(4):839-65. PubMed ID: 11842096 [TBL] [Abstract][Full Text] [Related]
12. Telomerase as a possible target for anticancer therapy. Autexier C Chem Biol; 1999 Nov; 6(11):R299-303. PubMed ID: 10574787 [TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Rankin AM; Faller DV; Spanjaard RA Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043 [TBL] [Abstract][Full Text] [Related]
14. Human telomerase inhibitors from microbial source. Kiran KG; Palaniswamy M; Angayarkanni J World J Microbiol Biotechnol; 2015 Sep; 31(9):1329-41. PubMed ID: 26130439 [TBL] [Abstract][Full Text] [Related]
15. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors. Saraswati AP; Relitti N; Brindisi M; Gemma S; Zisterer D; Butini S; Campiani G Drug Discov Today; 2019 Jul; 24(7):1370-1388. PubMed ID: 31136800 [TBL] [Abstract][Full Text] [Related]
16. [Telomere and telomerase in human cancer]. Hiyama K; Hiyama E; Ishioka S; Yamakido M Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230 [TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics. Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680 [TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition in cancer therapeutics: molecular-based approaches. Cunningham AP; Love WK; Zhang RW; Andrews LG; Tollefsbol TO Curr Med Chem; 2006; 13(24):2875-88. PubMed ID: 17073634 [TBL] [Abstract][Full Text] [Related]
19. Q&A: Elizabeth Blackburn on telomerase and tumors. Blackburn E Cancer Discov; 2013 Dec; 3(12):1323. PubMed ID: 24327681 [No Abstract] [Full Text] [Related]
20. Telomere biology of pediatric cancer. Tabori U; Dome JS Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]